Danaher Corporation acquired Aperio Technologies, a transaction completed in January 2012.
Aperio Technologies operates in Diagnostics (Leica Biosystems). Aperio is a digital-pathology line, offering slide-scanning and imaging systems for cancer diagnostics and laboratory workflows. Its products are marketed within Danaher's Leica Biosystems business, which supports the full pathology workflow from sample preparation and staining through imaging and reporting.
Expanded Danaher's diagnostics business in anatomical pathology.
... Beckman Coulter in 2011 (which more than doubled the size of the segment) and Iris International and Aperio Technologies in 2012.Danaher Corporation FY12 10-K, Item 1 Business description
Advisory firms were not disclosed for this transaction.